Garadacimab

Tax included
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
MedChemExpress 
HY-P99631

Data sheet

Size
Multiple sizes
Reactivity
Factor Xa
Application
Neuroscience-Neuromodulation
CAS
2162134-62-3